Recombinant human VEGF treatment enhances alveolarization after hyperoxic lung injury in neonatal rats.
Kunig AM, Balasubramaniam V, Markham NE, Morgan D, Montgomery G, Grover TR, Abman SH. Recombinant human VEGF treatment enhances alveolarization after hyperoxic lung injury in neonatal rats. Am J Physiol Lung Cell Mol Physiol. 2005 Oct; 289(4):L529-35.